Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Free Cash Flow (2019 - 2025)

AVITA Medical's Free Cash Flow history spans 7 years, with the latest figure at -$5.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 64.84% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$31.8 million, up 45.22%, while the annual FY2025 figure was -$31.8 million, 45.22% up from the prior year.
  • Free Cash Flow reached -$5.9 million in Q4 2025 per RCEL's latest filing, down from -$4.6 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $464000.0 in Q2 2022 to a low of -$22.0 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$9.1 million, with a median of -$9.3 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: surged 103.94% in 2022, then crashed 2086.2% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$599000.0 in 2021, then crashed by 547.91% to -$3.9 million in 2022, then crashed by 187.53% to -$11.2 million in 2023, then crashed by 50.95% to -$16.8 million in 2024, then surged by 64.84% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Free Cash Flow are -$5.9 million (Q4 2025), -$4.6 million (Q3 2025), and -$10.8 million (Q2 2025).